Asthma Medication       

FOI REFERENCE: 24292  FOI DATE:  12^th August 2024    

Q1. How many patients have been treated (for any condition) in the last 4 months with:

Benralizumab	28
Dupilumab	32
Omalizumab	17
Reslizumab	0
Mepolizumab	18
Tezepelumab	21

Q2. Of the patients treated in the last 4 months with any of the above products, please provide the number of patients by the following age-groups: 

Age 6-11	0
Age 12-17	*
Age 18 and above	114

Q3. How many patients have been treated in the last 4 months by the Respiratory Medicine department ONLY with:

Dupilumab	*
Omalizumab	16

*This relates to low numbers between 1 and 5. Under section 40 (ii) of the Freedom of Information Act 2000, statistically low numbers that potentially identify personal data are required to be withheld because of the Trusts obligation to protect personal data under the Data Protection Act 2018